Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors
Related Posts
Ju Y, Watson J, Wang JJ, Yen YT, Gevorkian L, Chen Z, Tu KH, Salumbides B, Phung A, Zhao C, Kim H, Ji YR, Zhang[...]
Highlights in metastatic breast cancer from the 2024 San Antonio Breast Cancer Symposium: commentary
Bardia A. Highlights in metastatic breast cancer from the 2024 San Antonio Breast Cancer Symposium: commentary. Clin Adv Hematol Oncol. 2025 Feb;23 Suppl 2(1):6-15. PMID:[...]
Wang R, Wang S, Mi Y, Huang T, Wang J, Ni J, Wang J, Yin J, Li M, Ran X, Fan S, Sun Q, Tan[...]